The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
DNA vaccines: precision tools for activating effective immunity against cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Cancer immunotherapy: moving beyond current vaccines
Rosenberg, S. A., Yang, J. C., & Restifo, N. P. (2004) · Nature Medicine · doi:10.1038/nm1100 · Cited by 2,972
CpG Motifs in Bacterial DNA and Their Immune Effects
Krieg, A. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064842 · Cited by 2,573
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
Albert, M. L., Sauter, B., & Bhardwaj, N. (1998) · Nature · doi:10.1038/32183 · Cited by 2,349
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes
Janssen, E. M., Lemmens, E. E., Wolfe, T., Christen, U., von Herrath, M. G., & Schoenberger, S. P. (2003) · Nature · doi:10.1038/nature01441 · Cited by 1,635
Phan, G. Q., Yang, J. C., Sherry, R. M., Hwu, P., Topalian, S. L., Schwartzentruber, D. J., Restifo, N. P., Haworth, L. R., Seipp, C. A., Freezer, L. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533209100 · Cited by 1,575
Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory
Shedlock, D. J., & Shen, H. (2003) · Science · doi:10.1126/science.1082305 · Cited by 1,460
Ghiringhelli, F., Menard, C., Puig, P. E., Ladoire, S., Roux, S., Martin, F., Solary, E., Le Cesne, A., Zitvogel, L., & Chauffert, B. (2007) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-006-0225-8 · Cited by 1,241
Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help
Sun, J. C., & Bevan, M. J. (2003) · Science · doi:10.1126/science.1083317 · Cited by 1,213
DNA Vaccines: Immunology, Application, and Optimization
Gurunathan, S., Klinman, D. M., & Seder, R. A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.927 · Cited by 1,207
Potent antibody therapeutics by design
Carter, P. J. (2006) · Nature Reviews Immunology · doi:10.1038/nri1837 · Cited by 1,099
Indoleamine 2,3-dioxygenase and tumor-induced tolerance
Munn, D. H., & Mellor, A. L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31178 · Cited by 1,078
Suzuki, E., Kapoor, V., Jassar, A. S., Kaiser, L. R., & Albelda, S. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0883 · Cited by 1,054
IMMUNODOMINANCE IN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I–RESTRICTED T LYMPHOCYTE RESPONSES
Yewdell, J. W., & Bennink, J. R. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.51 · Cited by 944
Gene transfer into muscle by electroporation in vivo
Aihara, H., & Miyazaki, J.-I. (1998) · Nature Biotechnology · doi:10.1038/nbt0998-867 · Cited by 944
High-efficiency gene transfer into skeletal muscle mediated by electric pulses
Mir, L. M., Bureau, M. F., Gehl, J., Rangara, R., Rouy, D., Caillaud, J.-M., Delaere, P., Branellec, D., Schwartz, B., & Scherman, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4262 · Cited by 914
Lutsiak, M. E. C., Semnani, R. T., De Pascalis, R., Kashmiri, S. V. S., Schlom, J., & Sabzevari, H. (2005) · Blood · doi:10.1182/blood-2004-06-2410 · Cited by 903
GOLDMAN, J. M., GALE, R. P., HOROWITZ, M. M., BIGGS, J. C., CHAMPLIN, R. E., GLUCKMAN, E., HOFFMANN, R. G., JACOBSEN, S. J., MARMONT, A. M., McGLAVE, P. B., et al. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-6-806 · Cited by 838
Signal Sequence Recognition and Protein Targeting to the Endoplasmic Reticulum Membrane
Walter, P., & Johnson, A. E. (1994) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.10.110194.000511 · Cited by 821
Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells
Williams, M. A., Tyznik, A. J., & Bevan, M. J. (2006) · Nature · doi:10.1038/nature04790 · Cited by 797
Differential Lysosomal Proteolysis in Antigen-Presenting Cells Determines Antigen Fate
Delamarre, L., Pack, M., Chang, H., Mellman, I., & Trombetta, E. S. (2005) · Science · doi:10.1126/science.1108003 · Cited by 774
GENETIC ANALYSIS OF HOST RESISTANCE: Toll-Like Receptor Signaling and Immunity at Large
Beutler, B., Jiang, Z., Georgel, P., Crozat, K., Croker, B., Rutschmann, S., Du, X., & Hoebe, K. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090552 · Cited by 772
Maloney, D., Liles, T., Czerwinski, D., Waldichuk, C., Rosenberg, J., Grillo-Lopez, A., & Levy, R. (1994) · Blood · doi:10.1182/blood.v84.8.2457.2457 · Cited by 762
ER–phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells
Guermonprez, P., Saveanu, L., Kleijmeer, M., Davoust, J., van Endert, P., & Amigorena, S. (2003) · Nature · doi:10.1038/nature01911 · Cited by 753
Cross‐presentation, dendritic cell subsets, and the generation of immunity to cellular antigens
Heath, W. R., Belz, G. T., Behrens, G. M. N., Smith, C. M., Forehan, S. P., Parish, I. A., Davey, G. M., Wilson, N. S., Carbone, F. R., & Villadangos, J. A. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00142.x · Cited by 735
Schneider, J., Gilbert, S. C., Blanchard, T. J., Hanke, T., Robson, K. J., Hannan, C. M., Becker, M., Sinden, R., Smith, G. L., & Hill, A. V. S. (1998) · Nature Medicine · doi:10.1038/nm0498-397 · Cited by 644
CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death
Janssen, E. M., Droin, N. M., Lemmens, E. E., Pinkoski, M. J., Bensinger, S. J., Ehst, B. D., Griffith, T. S., Green, D. R., & Schoenberger, S. P. (2005) · Nature · doi:10.1038/nature03337 · Cited by 619
Increased DNA Vaccine Delivery and Immunogenicity by Electroporation In Vivo
Widera, G., Austin, M., Rabussay, D., Goldbeck, C., Barnett, S. W., Chen, M., Leung, L., Otten, G. R., Thudium, K., Selby, M. J., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4635 · Cited by 606
McConkey, S. J., Reece, W. H. H., Moorthy, V. S., Webster, D., Dunachie, S., Butcher, G., Vuola, J. M., Blanchard, T. J., Gothard, P., Watkins, K., et al. (2003) · Nature Medicine · doi:10.1038/nm881 · Cited by 553
Tregs and rethinking cancer immunotherapy
Curiel, T. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31202 · Cited by 547
Cognate CD4+ T cell licensing of dendritic cells in CD8+ T cell immunity
Smith, C. M., Wilson, N. S., Waithman, J., Villadangos, J. A., Carbone, F. R., Heath, W. R., & Belz, G. T. (2004) · Nature Immunology · doi:10.1038/ni1129 · Cited by 448
Tumor‐specific shared antigenic peptides recognized by human T cells
Van Der Bruggen, P., Zhang, Y., Chaux, P., Stroobant, V., Panichelli, C., Schultz, E. S., Chapiro, J., Van den Eynde, B. J., Brasseur, F., & Boon, T. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18806.x · Cited by 378
Electropermeabilization of skeletal muscle enhances gene transfer in vivo
Mathiesen, I. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300847 · Cited by 372
The prime-boost strategy: exciting prospects for improved vaccination
Ramshaw, I. A., & Ramsay, A. J. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01612-1 · Cited by 369
Bergman, P. J., McKnight, J. A., Novosad, A., Charney, S. C., Farrelly, J., Craft, D. M., Wulderk, M., Jeffers, Y., Sadelain, M., Hohenhaus, A. E., et al. (2003) · PubMed · Cited by 330
Distribution of DNA Vaccines Determines Their Immunogenicity After Intramuscular Injection in Mice
Dupuis, M., Denis-Mize, K., Woo, C., Goldbeck, C., Selby, M. J., Chen, M., Otten, G. R., Ulmer, J. B., Donnelly, J. J., Ott, G., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2850 · Cited by 327
Wang, Z., Troilo, P. J., Wang, X., Griffiths, T. G., Pacchione, S. J., Barnum, A. B., Harper, L. B., Pauley, C. J., Niu, Z., Denisova, L., et al. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302213 · Cited by 322
Bergman, P. J., Camps-Palau, M. A., McKnight, J. A., Leibman, N. F., Craft, D. M., Leung, C., Liao, J., Riviere, I., Sadelain, M., Hohenhaus, A. E., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.08.027 · Cited by 298
King, C. A., Spellerberg, M. B., Zhu, D., Rice, J., Sahota, S. S., Thompsett, A. R., Hamblin, T. J., Radl, J., & Stevenson, F. K. (1998) · Nature Medicine · doi:10.1038/3266 · Cited by 292
Self-citationRapoport, A. P., Stadtmauer, E. A., Aqui, N., Badros, A., Cotte, J., Chrisley, L., Veloso, E., Zheng, Z., Westphal, S., Mair, R., et al. (2005) · Nature Medicine · doi:10.1038/nm1310 · Cited by 290
Arlen, P. M., Gulley, J. L., Parker, C., Skarupa, L., Pazdur, M., Panicali, D., Beetham, P., Tsang, K. Y., Grosenbach, D. W., Feldman, J., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2059 · Cited by 287
Nabel, G. J., Gordon, D., Bishop, D. K., Nickoloff, B. J., Yang, Z.-Y., Aruga, A., Cameron, M. J., Nabel, E. G., & Chang, A. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15388 · Cited by 239
Klencke, B. J., Matijevic, M., Urban, R. G., Lathey, J. L., Hedley, M. L., Berry, M. J., Thatcher, J., Weinberg, V., Wilson, J., Darragh, T. M., et al. (2002) · PubMed · Cited by 230
Boyle, J. (1997) · International Immunology · doi:10.1093/intimm/9.12.1897 · Cited by 222
Langerhans cells cross-present antigen derived from skin
Stoitzner, P., Tripp, C. H., Eberhart, A., Price, K. M., Jung, J. Y., Bursch, L., Ronchese, F., & Romani, N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509307103 · Cited by 218
Hamilton, S. E., Wolkers, M. C., Schoenberger, S. P., & Jameson, S. C. (2006) · Nature Immunology · doi:10.1038/ni1326 · Cited by 216
Luckay, A., Sidhu, M. K., Kjeken, R., Megati, S., Chong, S.-Y., Roopchand, V., Garcia-Hand, D., Abdullah, R., Braun, R., Montefiori, D. C., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00055-07 · Cited by 203
Spies, B., Hochrein, H., Vabulas, M., Huster, K., Busch, D. H., Schmitz, F., Heit, A., & Wagner, H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.5908 · Cited by 199
Cd40-Independent Pathways of T Cell Help for Priming of Cd8+ Cytotoxic T Lymphocytes
Lu, Z., Yuan, L., Zhou, X., Sotomayor, E., Levitsky, H. I., & Pardoll, D. M. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.3.541 · Cited by 196
Pavlenko, M., Roos, A.-K., Lundqvist, A., Palmborg, A., Miller, A. M., Ozenci, V, Bergman, B., Egevad, L., Hellström, M., Kiessling, R., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602019 · Cited by 195
Electroporation improves the efficacy of DNA vaccines in large animals
BABIUK, S. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00269-4 · Cited by 183
Mincheff, M., Tchakarov, S., Zoubak, S., Loukinov, D., Botev, C., Altankova, I., Georgiev, G., Petrov, S., & Meryman, H. T. (2000) · European Urology · doi:10.1159/000020281 · Cited by 183
Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma.
Timmerman, J. M., Singh, G., Hermanson, G., Hobart, P. M., Czerwinski, D. K., Taidi, B., Rajapaksa, R., Caspar, C. B., van Beckhoven, A., & Levy, R. (2002) · PubMed · Cited by 179
Fontaine, P., Roy-Proulx, G., Knafo, L., Baron, C., Roy, D.-C., & Perreault, C. (2001) · Nature Medicine · doi:10.1038/89907 · Cited by 178
A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression
Bins, A. D., Jorritsma, A., Wolkers, M. C., Hung, C.-F., Wu, T.-C., Schumacher, T. N. M., & Haanen, J. B. A. G. (2005) · Nature Medicine · doi:10.1038/nm1264 · Cited by 178
Firat, H., Garcia-Pons, F., Tourdot, S., Pascolo, S., Scardino, A., Garcia, Z., Michel, M.-L., Jack, R. W., Jung, G., Kosmatopoulos, K., et al. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199910)29:10<3112::aid-immu3112>3.0.co;2-q · Cited by 176
Chemical adjuvants for plasmid DNA vaccines
Greenland, J. R., & Letvin, N. L. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.120 · Cited by 160
Hung, C., Cheng, W., Hsu, K.-F., Chai, C., He, L., Ling, M. F., & Wu, T. ‐. (2001) · PubMed · Cited by 155
Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases
FULLER, D. H., Loudon, P. T., & Schmaljohn, C. S. (2006) · Methods · doi:10.1016/j.ymeth.2006.05.022 · Cited by 155
Rahman, F., Dahmen, A., Herzog‐Hauff, S., Böcher, W. O., Galle, P. R., & Löhr, H. F. (2000) · Hepatology · doi:10.1002/hep.510310237 · Cited by 153
Adjuvant Activity of CpG Oligodeoxynucleotides
Klinman, D. M. (2006) · International Reviews of Immunology · doi:10.1080/08830180600743057 · Cited by 148
Conry, R. M., Curiel, D. T., Strong, T. V., Moore, S. E., Allen, K. O., Barlow, D. L., Shaw, D. R., & LoBuglio, A. F. (2002) · PubMed · Cited by 147
Hernández, J., Aung, S., Marquardt, K., & Sherman, L. A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011612 · Cited by 136
Ahlén, G., Söderholm, J., Tjelle, T. E., Kjeken, R., Frelin, L., Höglund, U., Blomberg, P., Fons, M. P., Mathiesen, I., & Sällberg, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4741 · Cited by 135
Requirements for CD8 T-cell priming, memory generation and maintenance
Prlic, M., Williams, M. A., & Bevan, M. J. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.04.010 · Cited by 135
Phase I study of intranodal delivery of a plasmid DNA vaccine for patients with Stage IV melanoma
Tagawa, S. T., Lee, P. P., Snively, J., Boswell, W. D., Ounpraseuth, S., Lee, S., Hickingbottom, B., Smith, J. W., Johnson, D. L., & Weber, J. S. (2003) · Cancer · doi:10.1002/cncr.11462 · Cited by 134
Progress in DNA‐based heterologous prime‐boost immunization strategies for malaria
Moore, A., & Hill, A. V. S. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00138.x · Cited by 134
CD8 lethargy in the absence of CD4 help
Bourgeois, C., Veiga‐Fernandes, H., Joret, A., Rocha, B., & Tanchot, C. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200208)32:8<2199::aid-immu2199>3.0.co;2-l · Cited by 134
Preclinical and Clinical Safety Studies on DNA Vaccines
Schalk, J. A. C., Mooi, F. R., Berbers, G. A. M., van Aerts, L., Ovelgönne, H., & Kimman, T. G. (2006) · Human Vaccines · doi:10.4161/hv.2.2.2620 · Cited by 125
Rapid Death of Adoptively Transferred T Cells in Acquired Immunodeficiency Syndrome
Tan, R., Xu, X., Ogg, G. S., Hansasuta, P., Dong, T., Rostron, T., Luzzi, G. A., Conlon, C. P., Screaton, G. R., McMichael, A. J., et al. (1999) · Blood · doi:10.1182/blood.v93.5.1506 · Cited by 122
Nakajima, C., Uekusa, Y., 岩崎, 正., Yamaguchi, N., Mukai, T., Gao, P. H., Tomura, M., Ono, S., Tsujimura, T., Fujiwara, H., et al. (2001) · Cancer Research · Cited by 122
Stevenson, F. K., Ottensmeier, C. H. H., Johnson, P., Zhu, D., Buchan, S. L., McCann, K. J., Roddick, J. S., King, A. T., McNicholl, F. P., Savelyeva, N., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404896101 · Cited by 122
Self-citationEffective therapeutic anticancer vaccines based on precision guiding of cytolytic T lymphocytes
Melief, C. J. M., van der Burg, S. H., Toes, R. E. M., OSSENDORP, F. A., & Offringa, R. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18816.x · Cited by 110
Rosenberg, S. A., Yang, J. C.-H., Sherry, R. M., Hwu, P., Topalian, S. L., Schwartzentruber, D. J., Restifo, N. P., Haworth, L. R., Seipp, C. A., Rogers-Freezer, L. J., et al. (2003) · Human Gene Therapy · doi:10.1089/104303403765255110 · Cited by 109
Safety and Immunogenicity of Tyrosinase DNA Vaccines in Patients with Melanoma
Wolchok, J. D., Yuan, J. D., Houghton, A. N., Gallardo, H. F., Rasalan, T. S., Wang, J., Zhang, Y., Ranganathan, R., Chapman, P. B., Krown, S. E., et al. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300290 · Cited by 107
Electroporation as a “Prime/Boost” Strategy for Naked DNA Vaccination against a Tumor Antigen
Buchan, S. L., Grønevik, E., Mathiesen, I., KING, C. A., Stevenson, F. K., & Rice, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6292 · Cited by 103
Self-citationImmunodominance of Poxviral-Specific CTL in a Human Trial of Recombinant-Modified Vaccinia Ankara
Smith, C. S., Mirza, F., Pasquetto, V., Tscharke, D. C., Palmowski, M. J., Dunbar, P. R., Sette, A., Harris, A. L., & Cerundolo, V. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.8431 · Cited by 99
Rice, J., Elliott, T. J., Buchan, S. L., & Stevenson, F. K. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1558 · Cited by 97
Self-citationCalarota, S. A., & Weiner, D. B. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00150.x · Cited by 93
Kündig, T. M., Kalberer, C. P., Hengartner, H., & Zinkernagel, R. M. (1993) · Vaccine · doi:10.1016/0264-410x(93)90079-d · Cited by 90
Recovery of CD8+ T-Cell Function During Systemic Chemotherapy in Advanced Ovarian Cancer
Coleman, S. L., Clayton, A., Mason, M. D., Jasani, B., Adams, M., & Tabi, Z. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3792 · Cited by 90
Spellerberg, M. B., Zhu, D., Thompsett, A. R., KING, C. A., Hamblin, T. J., & Stevenson, F. K. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.4.1885 · Cited by 88
Self-citationSmith, C. S., Dunbar, P. R., Mirza, F., Palmowski, M. J., Shepherd, D., Gilbert, S. C., Coulie, P. G., Schneider, J., Hoffman, E. W., Hawkins, R. E., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20569 · Cited by 86
Chen, W., & McCluskey, J. (2006) · Advances in cancer research · doi:10.1016/s0065-230x(06)95006-4 · Cited by 81
Intensity of the Vaccine-Elicited Immune Response Determines Tumor Clearance
Pérez‐Díez, A., Spiess, P. J., Restifo, N. P., Matzinger, P., & Marincola, F. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.1.338 · Cited by 81
Breast cancer vaccines: maximizing cancer treatment by tapping into host immunity
Emens, L. A., Reilly, R. T., & Jaffee, E. M. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.00671 · Cited by 80
Rice, J., Buchan, S. L., & Stevenson, F. K. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3908 · Cited by 79
Self-citationDNA fusion gene vaccines against cancer: from the laboratory to the clinic
Stevenson, F. K., Rice, J., Ottensmeier, C. H. H., Thirdborough, S. M., & Zhu, D. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00145.x · Cited by 78
Self-citationZavala, F. P., Rodrigues, M. M., Rodrı́guez, D., Rodríguez, J. R., Nussenzweig, R. S., & Estéban, M. (2001) · Virology · doi:10.1006/viro.2000.0792 · Cited by 77
Suzuki, E., Sun, J., Kapoor, V., Jassar, A. S., & Albelda, S. Μ. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.6.4090 · Cited by 77
Targeting plasmid‐encoded proteins to the antigen presentation pathways
Leifert, J. A., Rodriguez‐Carreno, M. P., Rodrı́guez, F., & Whitton, J. L. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.0135.x · Cited by 76
Miller, A. M., Özenci, V., Kiessling, R. W., & Pisa, P. (2005) · Journal of Immunotherapy · doi:10.1097/01.cji.0000165353.19171.41 · Cited by 75
Böcher, W. O., Herzog‐Hauff, S., Schlaak, J., Büschenfelde, K. M. Z., & Löhr, H. F. (1999) · Hepatology · doi:10.1002/hep.510290120 · Cited by 74
Todorova, K. O., Ignatova, I., Tchakarov, S., Altankova, I., Zoubak, S., Kyurkchiev, S., & Mincheff, M. S. (2005) · PubMed · Cited by 74
Genova, G. D., Roddick, J., McNicholl, F. P., & Stevenson, F. K. (2005) · Blood · doi:10.1182/blood-2005-08-3255 · Cited by 73
Self-citationPotential of Transfected Muscle Cells to Contribute to DNA Vaccine Immunogenicity
Shirota, H., Petrenko, L., Hong, C., & Klinman, D. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.329 · Cited by 72
PML-RARA–targeted DNA vaccine induces protective immunity in a mouse model of leukemia
Padua, R. A., Larghero, J., Robin, M., Pogam, C. L., Schlageter, M., Muszlak, S., Frič, J., West, R., Rousselot, P. H., Phan, T. H., et al. (2003) · Nature Medicine · doi:10.1038/nm949 · Cited by 70
Self-citationBačík, I., Snyder, H. L., Antón, L. C., Russ, G., Chen, W., Bennink, J. R., Ürge, L., Ötvös, L., Dudkowska, B., Eisenlohr, L. C., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.4.479 · Cited by 70
Immunity to Cancer Through Immune Recognition of Altered Self: Studies with Melanoma
Guevara-Patino, J. A., Turk, M. J., Wolchok, J. D., & Houghton, A. N. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)90005-4 · Cited by 66
Helper Requirements for Generation of Effector CTL to Islet β Cell Antigens
Behrens, G. M. N., Li, M., Davey, G. M., Allison, J., Flavell, R. A., Carbone, F., & Heath, W. R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5420 · Cited by 63
The regulation of DNA vaccines
Smith, H. A., & Klinman, D. M. (2001) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(00)00215-9 · Cited by 61
Observing the invisible: successful tumor immunity in humans
Darnell, R. B., & Posner, J. B. (2003) · Nature Immunology · doi:10.1038/ni0303-201 · Cited by 56
Triozzi, P. L., Aldrich, W. A., Allen, K. O., Carlisle, R. R., LoBuglio, A. F., & Conry, R. M. (2005) · Journal of Immunotherapy · doi:10.1097/01.cji.0000162779.88687.4c · Cited by 53
VALONE, F. H., KAUFMAN, P. A., GUYRE, P. M., LEWIS, L. D., MEMOLI, V., ERNSTOFF, M. S., WELLS, W., BARTH, R., DEO, Y., FISHER, J., et al. (1995) · Journal of Hematotherapy · doi:10.1089/scd.1.1995.4.471 · Cited by 48
Clinical utilization of chemokines to combat cancer: the double-edged sword
Dell’Agnola, C., & Biragyn, A. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.2.267 · Cited by 48
Towards progress on DNA vaccines for cancer
Lowe, D. B., Shearer, M. H., Jumper, C., & Kennedy, R. C. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7165-0 · Cited by 46
CD4+ T Cells Can Protect APC from CTL-Mediated Elimination
Mueller, S. N., Jones, C. M., Stock, A. T., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7379 · Cited by 41
Optimizing the Efficacy of Epitope-Directed DNA Vaccination
Wolkers, M. C., Toebes, M., Okabe, M., Haanen, J. B. A. G., & Schumacher, T. N. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.4998 · Cited by 40
Genetic Analysis of Innate Immunity
Hoebe, K. H. N., Jiang, Z., Tabeta, K., Du, X., Georgel, P., Crozat, K., & Beutler, B. (2006) · Advances in immunology · doi:10.1016/s0065-2776(06)91005-0 · Cited by 39
Radcliffe, J. N., Roddick, J. S., Friedmann, P. S., Stevenson, F. K., & Thirdborough, S. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.6626 · Cited by 38
Self-citationWilcox, R. A., Flies, D. B., Wang, H., Tamada, K., Johnson, A. J., Pease, L. R., Rodriguez, M., Guo, Y., & Chen, L. (2002) · PubMed · Cited by 29
Cancer immunotherapy with chemoattractant peptides
Coscia, M., & Biragyn, A. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.10.008 · Cited by 22
The Cooperation between Two CD4 T Cells Induces Tumor Protective Immunity in MUC.1 Transgenic Mice
Gerloni, M., Castiglioni, P., & Zanetti, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6551 · Cited by 22
Stevenson, F. K., Rice, J., & Zhu, D. (2004) · Advances in immunology · doi:10.1016/s0065-2776(04)82002-9 · Cited by 22
Self-citationStevenson, F. K., Genova, G. D., Ottensmeier, C. H. H., & Savelyeva, N. (2007) · Elsevier eBooks · doi:10.1016/b978-012372551-6/50075-4 · Cited by 4
Self-citation
Cited by
Immune evasion in cancer: mechanistic basis and therapeutic strategies
Vinay, D. S., Ryan, E. P., Pawelec, G., Talib, W. H., Stagg, J., Elkord, E., Lichtor, T., Decker, W. K., Whelan, R. L., Kumara, H. M. C. S., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.004 · Cited by 1,625
Personalized vaccines for cancer immunotherapy
Sahin, U., & Türeci, Ö. (2018) · Science · doi:10.1126/science.aar7112 · Cited by 1,147
DNA vaccines: ready for prime time?
Kutzler, M. A., & Weiner, D. B. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2432 · Cited by 1,077
Neoantigens: promising targets for cancer therapy
Xie, N., Shen, G., Gao, W., Huang, Z., Huang, C., & Fu, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01270-x · Cited by 1,020
Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines
Melief, C. J. M., & van der Burg, S. H. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2373 · Cited by 594
Metadata
- Authors
- Rice, J., Ottensmeier, C. H., & Stevenson, F. K.
- Venue
- Nature Reviews Cancer
- Published
- 2008-02
- Volume
- 8
- Issue
- 2
- Pages
- 108-120
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2055186346
- Cited by
- 415
- References
- 115
- FWCI
- 2.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.